TD2 Announces Publication of Phase II Ketogenic Diet Trial Showing Improved Survival in Metastatic Pancreatic Cancer
Company Served as Sponsor and Provided Operational Leadership for Study Conducted in Partnership with TGen and Virta Health SCOTTSDALE, AZ, UNITED STATES, March 19, 2026 /EINPresswire.com/ -- TD2 Oncology, a leading oncology-focused contract research …